Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

Losartan+HCT Mevon Tablet 100/25mg

Approval Number

SIN13778P

Drug Name

Losartan+HCT Mevon Tablet 100/25mg

Product Name

Losartan+HCT Mevon Tablet 100/25mg

Approval Date

March 23, 2010

Registrant

NOVEM PHARMA PRIVATE LIMITED

Licence Holder

NOVEM PHARMA PRIVATE LIMITED

Regulatory Information

Registrant

NOVEM PHARMA PRIVATE LIMITED

Licence Holder

NOVEM PHARMA PRIVATE LIMITED

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

C09DA01

ATC Item Name

losartan and diuretics

Manufacturer Information

Pharmaceutical Manufacturer

NOVEM PHARMA PRIVATE LIMITED

Manufacturers

Pharmathen S.A.

Active Ingredients

Ingredient Name

LOSARTAN EQV LOSARTAN POTASSIUM

Strength

100 mg

Drug MonographLosartan

Ingredient Name

Hydrochlorothiazide

Strength

25mg

Drug MonographHydrochlorothiazide

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

Losartan+HCT Mevon Tablet 100/25mg - HSA Approval | MedPath